Ascletis Pharma Inc. logo

Ascletis Pharma Inc.

HKEX:1672.HK

Overview | Financials
Company Name Ascletis Pharma Inc.
Symbol 1672.HK
Currency HKD
Price 1.04
Market Cap 1,022,051,680
Dividend Yield 0%
52-week-range 0.76 - 2.05
Industry Biotechnology
Sector Healthcare
CEO Dr. Jinzi Jason Wu Ph.D.
Website https://www.ascletis.com

An error occurred while fetching data.

About Ascletis Pharma Inc.

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug

Related Stocks

MicroTech Medical (Hangzhou) Co., Ltd. logo

MicroTech Medical (Hangzhou) Co., Ltd.

2235.HK

3.57 HKD

Peijia Medical Limited logo

Peijia Medical Limited

9996.HK

2.89 HKD

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. logo

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

1558.HK

8.19 HKD

Antengene Corporation Limited logo

Antengene Corporation Limited

6996.HK

0.54 HKD

Viva Biotech Holdings logo

Viva Biotech Holdings

1873.HK

0.61 HKD

AK Medical Holdings Limited logo

AK Medical Holdings Limited

1789.HK

4.15 HKD

Hua Medicine (Shanghai) Ltd. logo

Hua Medicine (Shanghai) Ltd.

2552.HK

1.19 HKD

Ascentage Pharma Group International logo

Ascentage Pharma Group International

6855.HK

37.65 HKD

Consun Pharmaceutical Group Limited logo

Consun Pharmaceutical Group Limited

1681.HK

6.03 HKD

China Shineway Pharmaceutical Group Limited logo

China Shineway Pharmaceutical Group Limited

2877.HK

7.86 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD